En+ Group MKPAO
MOEX:ENPG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
En+ Group MKPAO
MOEX:ENPG
|
RU |
|
Sarepta Therapeutics Inc
NASDAQ:SRPT
|
US |
|
Hongkong and Shanghai Hotels Ltd
HKEX:45
|
HK |
|
ABC Arbitrage SA
OTC:ABCCF
|
FR |
|
Lithium Chile Inc
XTSX:LITH
|
CA |
|
C
|
Chico's FAS Inc
F:YC8
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ENPG's stock price target?
Not Available
ENPG doesn't have any price targets made by Wall Street professionals.
What is En+ Group MKPAO's Revenue forecast?
Projected CAGR
-4%
For the last 4 years the
compound annual growth rate for
En+ Group MKPAO's revenue is
9%.
The projected
CAGR
for the next 3 years is
-4%.
What is En+ Group MKPAO's Operating Income forecast?
Projected CAGR
8%
For the last 4 years the
compound annual growth rate for
En+ Group MKPAO's operating income is
19%.
The projected
CAGR
for the next 3 years is
8%.
What is En+ Group MKPAO's Net Income forecast?
Projected CAGR
33%
For the last 4 years the
compound annual growth rate for
En+ Group MKPAO's net income is
10%.
The projected
CAGR
for the next 3 years is
33%.
